302 related articles for article (PubMed ID: 29245156)
1. Selection and targeting of EpCAM protein by ssDNA aptamer.
Alshaer W; Ababneh N; Hatmal M; Izmirli H; Choukeife M; Shraim A; Sharar N; Abu-Shiekah A; Odeh F; Al Bawab A; Awidi A; Ismail S
PLoS One; 2017; 12(12):e0189558. PubMed ID: 29245156
[TBL] [Abstract][Full Text] [Related]
2. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
[TBL] [Abstract][Full Text] [Related]
3. In silico design and validation of high-affinity RNA aptamers targeting epithelial cellular adhesion molecule dimers.
Bell DR; Weber JK; Yin W; Huynh T; Duan W; Zhou R
Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8486-8493. PubMed ID: 32234785
[TBL] [Abstract][Full Text] [Related]
4. In silico designed RNA aptamer against epithelial cell adhesion molecule for cancer cell imaging.
Bavi R; Liu Z; Han Z; Zhang H; Gu Y
Biochem Biophys Res Commun; 2019 Feb; 509(4):937-942. PubMed ID: 30648555
[TBL] [Abstract][Full Text] [Related]
5. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
[TBL] [Abstract][Full Text] [Related]
6. A Flow Cytometry-based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer.
Nakhjavani M; Giles B; Strom M; Vi C; Attenborough S; Shigdar S
J Vis Exp; 2022 Sep; (187):. PubMed ID: 36190297
[TBL] [Abstract][Full Text] [Related]
7. RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule.
Shigdar S; Lin J; Yu Y; Pastuovic M; Wei M; Duan W
Cancer Sci; 2011 May; 102(5):991-8. PubMed ID: 21281402
[TBL] [Abstract][Full Text] [Related]
8. Identification of DNA aptamers toward epithelial cell adhesion molecule via cell-SELEX.
Kim JW; Kim EY; Kim SY; Byun SK; Lee D; Oh KJ; Kim WK; Han BS; Chi SW; Lee SC; Bae KH
Mol Cells; 2014 Oct; 37(10):742-6. PubMed ID: 25266702
[TBL] [Abstract][Full Text] [Related]
9. RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.
Mittelberger F; Meyer C; Waetzig GH; Zacharias M; Valentini E; Svergun DI; Berg K; Lorenzen I; Grötzinger J; Rose-John S; Hahn U
RNA Biol; 2015; 12(9):1043-53. PubMed ID: 26383776
[TBL] [Abstract][Full Text] [Related]
10. Probing the biophysical interaction between Neocarzinostatin toxin and EpCAM RNA aptamer.
Athyala PK; Kanwar JR; Alameen M; Kanwar RK; Krishnakumar S; Watson J; Vetrivel U; Narayanan J
Biochem Biophys Res Commun; 2016 Jan; 469(2):257-62. PubMed ID: 26642954
[TBL] [Abstract][Full Text] [Related]
11. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
[TBL] [Abstract][Full Text] [Related]
12. Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer.
Subramanian N; Raghunathan V; Kanwar JR; Kanwar RK; Elchuri SV; Khetan V; Krishnakumar S
Mol Vis; 2012; 18():2783-95. PubMed ID: 23213278
[TBL] [Abstract][Full Text] [Related]
13. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro.
Alibolandi M; Ramezani M; Sadeghi F; Abnous K; Hadizadeh F
Int J Pharm; 2015 Feb; 479(1):241-51. PubMed ID: 25529433
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal surface display SELEX for simple, rapid, efficient, and cost-effective aptamer enrichment and identification.
Zhu Z; Song Y; Li C; Zou Y; Zhu L; An Y; Yang CJ
Anal Chem; 2014 Jun; 86(12):5881-8. PubMed ID: 24863283
[TBL] [Abstract][Full Text] [Related]
15. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
[TBL] [Abstract][Full Text] [Related]
16. EpCAM-Targeting Aptamer Radiotracer for Tumor-Specific PET Imaging.
Li F; Zeng Z; Hamilton D; Zu Y; Li Z
Bioconjug Chem; 2021 Jun; 32(6):1139-1145. PubMed ID: 34014641
[TBL] [Abstract][Full Text] [Related]
17. [Enhancement of thermal damage to EpCAM-positive tumor cells by novel aptamer-guided magnetic nanoparticles].
Zhang LY; Wang M; Wu HB; Yang Y; Li Q; Sun HL
Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):726-731. PubMed ID: 29061014
[No Abstract] [Full Text] [Related]
18. Anti-epithelial cell adhesion molecule RNA aptamer-conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model.
Mashreghi M; Zamani P; Karimi M; Mehrabian A; Arabsalmani M; Zarqi J; Moosavian SA; Jaafari MR
Biotechnol Prog; 2021 May; 37(3):e3116. PubMed ID: 33369269
[TBL] [Abstract][Full Text] [Related]
19. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
[TBL] [Abstract][Full Text] [Related]
20. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.
Lu M; Zhou L; Zheng X; Quan Y; Wang X; Zhou X; Ren J
Cancer Biomark; 2015; 15(2):163-70. PubMed ID: 25519016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]